Overview
Persistent Intermenstrual Bleeding is a system-generated notification that alerts users when spotting or bleeding between periods has been logged repeatedly across multiple menstrual cycles. While occasional spotting can be normal (such as ovulation spotting), persistent or recurrent intermenstrual bleeding may indicate underlying conditions requiring medical evaluation.
This notification is triggered when the Cycle Tracking algorithm detects a pattern of intermenstrual bleeding logged in multiple cycles over the tracking period. It serves as an early warning to prompt users to discuss this pattern with their healthcare provider.
Health Significance
Persistent intermenstrual bleeding requires clinical attention as it may indicate:
- Cervical pathology: Cervical polyps, ectropion, or dysplasia can cause recurrent spotting
- Endometrial abnormalities: Polyps, hyperplasia, or (rarely) malignancy
- Uterine fibroids: Submucosal fibroids particularly cause abnormal bleeding
- Infections: Chronic cervicitis, STIs, or pelvic inflammatory disease
- Hormonal contraceptive effects: Breakthrough bleeding with pills, IUD, or implant (especially in first 3-6 months)
- Thyroid dysfunction: Can cause various abnormal bleeding patterns
- Coagulation disorders: May manifest as persistent abnormal bleeding
- Malignancy: Cervical or endometrial cancer (particularly concerning in older women or postmenopausal)
Recurrent pattern across multiple cycles increases clinical significance compared to isolated spotting.
Clinical Interpretation Guidelines
When evaluating persistent intermenstrual bleeding notifications:
- Pattern characterization:
- Frequency: How many cycles have included spotting?
- Timing: Is spotting mid-cycle (possibly ovulatory) or random?
- Relation to intercourse: Post-coital bleeding suggests cervical cause
- Amount: Spotting vs. heavier bleeding between periods
- Age-based considerations:
- Reproductive age: More likely benign causes (hormonal, structural)
- Perimenopause: Hormonal fluctuation common but evaluation still warranted
- Postmenopause: ANY bleeding requires prompt evaluation for malignancy
- Clinical workup:
- Pelvic examination with cervical visualization
- Cervical cancer screening (Pap test, HPV test) if not current
- STI testing if risk factors present
- Pelvic ultrasound (transvaginal preferred) to assess uterus and endometrium
- Endometrial biopsy if indicated by age, risk factors, or ultrasound findings
- Consider hysteroscopy for direct visualization
- Contraceptive correlation:
- Hormonal IUD: Spotting common for first 3-6 months
- Progestin-only methods: Irregular bleeding is a known side effect
- Combined oral contraceptives: Breakthrough bleeding may indicate need for different formulation
- Red flags requiring urgent evaluation:
- Postmenopausal bleeding
- Associated pelvic pain or pressure
- Constitutional symptoms (weight loss, fatigue)
- Abnormal cervical appearance on exam
Caveats & Limitations
- Read-only system notification; users cannot manually create this sample
- Depends on user logging intermenstrual bleeding samples consistently
- Algorithm specifics (number of cycles, frequency threshold) are not publicly disclosed
- Does not distinguish between spotting amount or bleeding severity
- Cannot differentiate between cervical, uterine, or vaginal bleeding sources
- Ovulation spotting logged repeatedly may trigger notification despite being physiological
- Hormonal contraceptive-related bleeding is common and may trigger notification appropriately
- Notification does not indicate cause; clinical evaluation is required
- May not account for known benign causes already under medical management
- Postpartum spotting patterns during cycle normalization may trigger notification